Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Total Liabilities (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Total Liabilities data on record, last reported at $59.8 million in Q4 2025.

  • For Q4 2025, Total Liabilities rose 58.71% year-over-year to $59.8 million; the TTM value through Dec 2025 reached $59.8 million, up 58.71%, while the annual FY2025 figure was $59.8 million, 58.71% up from the prior year.
  • Total Liabilities reached $59.8 million in Q4 2025 per PRAX's latest filing, up from $52.9 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $59.8 million in Q4 2025 and bottomed at $18.3 million in Q4 2023.
  • Average Total Liabilities over 4 years is $36.0 million, with a median of $35.8 million recorded in 2023.
  • Peak YoY movement for Total Liabilities: plummeted 53.16% in 2023, then skyrocketed 121.32% in 2025.
  • A 4-year view of Total Liabilities shows it stood at $39.0 million in 2022, then plummeted by 53.16% to $18.3 million in 2023, then skyrocketed by 106.03% to $37.7 million in 2024, then surged by 58.71% to $59.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $59.8 million in Q4 2025, $52.9 million in Q3 2025, and $48.6 million in Q2 2025.